ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)
$1.46 0.06 (4.2857%)
Analysed ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) News Sources
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
15-07-2026
yahoo.com
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
04-08-2026
yahoo.com
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
12-08-2026
yahoo.com
Allogene Therapeutics Q2 Earnings Call Highlights
12-08-2026
marketbeat.com
Allogene Therapeutics Inc (ALLO) (Q2 2026) Earnings Call Highlights: RMAT Designation and Rapid ...
13-08-2026
yahoo.com
Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says
13-08-2026
yahoo.com
Allogene Therapeutics' Q2 Earnings Beat Estimates on Lower R&D Costs
13-08-2026
yahoo.com
Allogene (ALLO) Q2 2026 Earnings Call Transcript
19-08-2026
fool.com
Allogene Therapeutics Announces Participation in September Investor Conference
31-08-2026
yahoo.com
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
02-09-2026
yahoo.com
What is the current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is $1.46.
ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is $0.06.
ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is 4.2857%.
What is the most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?
The most recent sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is .
SEC-8K** Filing Available For ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.